B7-H3 was Highly Expressed in Human Primary Hepatocellular Carcinoma and Promoted Tumor Progression

REFERENCES

• Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515–548.
   PubMed Web of Science ®Google Scholar
• Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999;402(6763):827–832.
   PubMed Web of Science ®Google Scholar
• Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, Mizuno T. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res 2005;11(8):2947–2953.
   PubMed Web of Science ®Google Scholar
• Sun J, Xu K, Wu C, Wang Y, Hu Y, Zhu Y. PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies. Tissue Antigens 2007;69(1):19–27.
   PubMed Web of Science ®Google Scholar
• Chen C, Qu QX, Shen Y, Mu CY, Zhu YB, Zhang XG. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Cancer Lett 2012;317(1):99–105.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007;67(18):8900–8905.
   PubMed Web of Science ®Google Scholar
• Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001;2(3):269–274.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006;53(2):143–151.
   PubMed Web of Science ®Google Scholar
• Suh WK, Gajewska BU, Okada H, Gronski MA, Bertram EM, Dawicki W. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 2003;4(9):899–906.
   PubMed Web of Science ®Google Scholar
• Ling V, Wu PW, Spaulding V, Kieleczawa J, Luxenberg D, Carreno BM. Duplication of primate and rodent B7-H3 immunoglobulin V-and C-like domains: divergent history of functional redundancy and exon loss. Genomics 2003;82(3):365–377.
   PubMed Web of Science ®Google Scholar
• Castriconi R, Dondero A, Augugliaro R, Cantoni C, Carnemolla B, Sementa AR. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci USA 2004; 101(34):12640–12645.
   PubMed Web of Science ®Google Scholar
• Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, Wang Y. Murine B7-H3 is a negative regulator of T cells. J Immunol 2004;173(4):2500–2506.
   PubMed Web of Science ®Google Scholar
• Wang L, Fraser CC, Kikly K, Wells AD, Han R, Coyle AJ. B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol 2005;35(2):428–438.
   PubMed Web of Science ®Google Scholar
• Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yamazaki T. B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 2007;113(1):52–57.
   PubMed Web of Science ®Google Scholar
• Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, Azuma M. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci USA 2008;105(30):10495–10500.
   PubMed Web of Science ®Google Scholar
• Hofmeyer KA, Ray A, Zang X. The contrasting role of B7-H3. Proc Natl Acad Sci USA 2008;105(30):10277–10278.
   PubMed Web of Science ®Google Scholar
• Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu KF. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 2006;12(3):457–459.
   PubMed Web of Science ®Google Scholar
• Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 2007;104(49):19458–19463.
   PubMed Web of Science ®Google Scholar
• Corcoran A, Mahon BP, McParland P, Davoren A, Doyle S. Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women. J Med Virol 2003;70(3):475–480.
   PubMed Web of Science ®Google Scholar
• Zhang GB, Zhou H, Chen YJ, Ge Y, Xie F, Shi Q. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells. Tissue Antigens 2005;66(2):83–92.
   PubMed Web of Science ®Google Scholar
• Prasad DV, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18(6):863–873.
   PubMed Web of Science ®Google Scholar
• Wojas-Turek J, Pajtasz-Piasecka E, Rossowska J, Piasecki E, Duś D. Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene. Folia Histochem Cytobiol. 2012;50(3):414–419.
   Google Scholar
• Tarhini AA, Gogas H, Kirkwood JM. IFN-α in the treatment of melanoma. J Immunol 2012;189(8):3789–3793.
   PubMed Web of Science ®Google Scholar
• Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S. B7-H4 Expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer 2009;19(9):1481–1486.
   PubMed Web of Science ®Google Scholar
• Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, Tan Y. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 2010;59(8):1163–1171.
   PubMed Web of Science ®Google Scholar
• Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res 2007;67(16):7893–7900.
   PubMed Web of Science ®Google Scholar
• Chen YW, Tekle C, Fodstad O. The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Targets 2008;8(5):404–413.
   PubMed Web of Science ®Google Scholar
• Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 2008;14(16):5150–5157.
   PubMed Web of Science ®Google Scholar
• Loos M, Hedderich D, Ottenhausen M, Giese NA, Laschinger M, Esposito I. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer 2009;9:463–472.
   PubMed Web of Science ®Google Scholar
• Zhang G, Xu Y, Lu X. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer 2009;66(2):245–249.
   PubMed Web of Science ®Google Scholar
• Wang F, Yu G, Liu T, Wang G, Yang J, Zhang G, Luan X. Expression and clinical significance of soluble B7- H3(sB7- H3) in serum of hepatocellular carcinoma patient. Chin J of Cell Mol Immunol 2013;29(6):629–632.
   Google Scholar
• Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S. B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer 2009;19(9):1481–1486.
   PubMed Web of Science ®Google Scholar